BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 32534593)

  • 21. Non-dilated left ventricular cardiomyopathy vs. dilated cardiomyopathy: clinical background and outcomes.
    Eda Y; Nabeta T; Iikura S; Takigami Y; Fujita T; Iida Y; Ikeda Y; Ishii S; Ako J
    ESC Heart Fail; 2024 Jun; 11(3):1463-1471. PubMed ID: 38320776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Echocardiographic Features Beyond Ejection Fraction and Associated Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
    Peters AE; Clare RM; Chiswell K; Felker GM; Kelsey A; Mentz R; DeVore AD
    Circ Heart Fail; 2023 May; 16(5):e010252. PubMed ID: 37192287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic microvascular complications are associated with reduced global longitudinal strain independent of atherosclerotic coronary artery disease in asymptomatic patients with diabetes mellitus: a cross-sectional study.
    Pararajasingam G; Heinsen LJ; Larsson J; Andersen TR; Løgstrup BB; Auscher S; Hangaard J; Møgelvang R; Egstrup K
    BMC Cardiovasc Disord; 2021 Jun; 21(1):269. PubMed ID: 34078282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of myocardial scars on left ventricular deformation in type 2 diabetes mellitus after myocardial infarction by contrast-enhanced cardiac magnetic resonance.
    Gao Y; Xu HY; Guo YK; Wen XL; Shi R; Li Y; Yang ZG
    Cardiovasc Diabetol; 2021 Oct; 20(1):215. PubMed ID: 34696783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The additive effects of kidney dysfunction on left ventricular function and strain in type 2 diabetes mellitus patients verified by cardiac magnetic resonance imaging.
    Zhang Y; Wang J; Ren Y; Yan WF; Jiang L; Li Y; Yang ZG
    Cardiovasc Diabetol; 2021 Jan; 20(1):11. PubMed ID: 33413395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac MRI Risk Stratification for Dilated Cardiomyopathy with Left Ventricular Ejection Fraction of 35% or Higher.
    Li S; Wang Y; Yang W; Zhou D; Zhuang B; Xu J; He J; Yin G; Fan X; Wu W; Sharma P; Sirajuddin A; Arai AE; Zhao S; Lu M
    Radiology; 2023 Mar; 306(3):e213059. PubMed ID: 36318031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular global longitudinal strain as a prognosticator in hypertrophic cardiomyopathy with a low-normal left ventricular ejection fraction.
    Choi YJ; Lee HJ; Park JS; Park CS; Rhee TM; Choi JY; Choi HM; Park JB; Yoon YE; Lee SP; Na JO; Cho GY; Kim YJ; Hwang IC; Kim HK
    Eur Heart J Cardiovasc Imaging; 2023 Sep; 24(10):1374-1383. PubMed ID: 37467475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of Global Longitudinal Strain for Identification and Monitoring of Left Ventricular Dysfunction in Becker Muscular Dystrophy.
    van de Velde NM; Gegenava T; Koeks Z; Butcher SC; Roest AA; Bax JJ; Atsma DE; Spitali P; Ajmone Marsan N; Niks EH
    Am J Cardiol; 2022 Jan; 162():170-176. PubMed ID: 34756724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional echocardiographic left ventricular strain analysis in Fabry disease: correlation with heart failure severity, myocardial scar, and impact on long-term prognosis.
    Marek J; Chocholová B; Rob D; Paleček T; Mašek M; Dostálová G; Linhart A
    Eur Heart J Cardiovasc Imaging; 2023 Nov; 24(12):1629-1637. PubMed ID: 37309820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term prognostic value of changes in left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction.
    Sakaguchi E; Yamada A; Naruse H; Hattori H; Nishimura H; Kawai H; Muramatsu T; Ishii J; Hata T; Saito K; Izawa H
    Heart Vessels; 2023 May; 38(5):645-652. PubMed ID: 36450933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemoglobin A1c in type 2 diabetes mellitus patients with preserved ejection fraction is an independent predictor of left ventricular myocardial deformation and tissue abnormalities.
    Li Z; Han D; Qi T; Deng J; Li L; Gao C; Gao W; Chen H; Zhang L; Chen W
    BMC Cardiovasc Disord; 2023 Jan; 23(1):49. PubMed ID: 36698087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggravating effect of obstructive sleep apnoea on left ventricular remodelling and function disorder in patients with type 2 diabetes mellitus: a case-control study by 3D speckle tracking echocardiography.
    Wang Q; Fu C; Xia H; Gao Y
    Acta Cardiol; 2022 Oct; 77(8):734-743. PubMed ID: 34514948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of pretransplant T2DM on left ventricular deformation and myocardial perfusion in heart transplanted recipients: a 3.0 T cardiac magnetic resonance study.
    Cao L; Liu C; Ou C; Ma Q; Xu H; Li X; Bao Y; Chen R; Yang Y; Wu M; Liu H
    Cardiovasc Diabetol; 2024 Jun; 23(1):216. PubMed ID: 38907259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of cardiac magnetic resonance derived global longitudinal strain analysis in patients with ischaemic and non-ischaemic dilated cardiomyopathy: a systematic review and meta-analysis.
    Fong LCW; Lee NHC; Poon JWL; Chin CWL; He B; Luo L; Chen C; Wan EYF; Pennell DJ; Mohiaddin R; Ng MY
    Int J Cardiovasc Imaging; 2022 Dec; 38(12):2707-2721. PubMed ID: 36445666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of peripheral neuropathy with subclinical left ventricular dysfunction in patients with type 2 diabetes.
    Chen Y; Wang Y; Zhang Y; Li M; Zhang W; Zhou Y; Liu X; Fu J; Lu Z; Xu Q; Liu T; Li Z; Li X; Zhou J
    J Diabetes Complications; 2023 Feb; 37(2):108406. PubMed ID: 36682230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of biomarkers and risk scores with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus.
    Halabi A; Potter E; Yang H; Wright L; Sacre JW; Shaw JE; Marwick TH
    Cardiovasc Diabetol; 2022 Dec; 21(1):278. PubMed ID: 36494683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis.
    Fairley JL; Hansen D; Proudman S; Sahhar J; Ngian GS; Walker J; Host LV; La Gerche A; Prior D; Burns A; Morrisroe K; Stevens W; Nikpour M; Ross L
    Semin Arthritis Rheum; 2024 Jun; 66():152443. PubMed ID: 38631275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Clinical Course and Outcomes between Dilated and Hypokinetic Non-Dilated Cardiomyopathy.
    Dziewięcka E; Winiarczyk M; Wiśniowska-Śmiałek S; Karabinowska-Małocha A; Robak J; Kaciczak M; Baranowski F; Rubiś P
    Cardiology; 2023; 148(5):395-401. PubMed ID: 37311443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of T2DM on right ventricular systolic dysfunction and interventricular interactions in patients with essential hypertension: evaluation using CMR tissue tracking.
    Li XM; Yan WF; Jiang L; Shi K; Ren Y; Han PL; Peng LQ; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2022 Nov; 21(1):238. PubMed ID: 36352469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incremental prognostic value of left atrial and biventricular feature tracking in dilated cardiomyopathy: a long-term study.
    Xiang X; Song Y; Zhao K; Yu S; Yang S; Xu J; Wang J; Dong Z; Ma X; Wei Z; Tang Y; Lu M; Zhao S; Chen X
    J Cardiovasc Magn Reson; 2023 Dec; 25(1):76. PubMed ID: 38057892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.